ROXANA AMAYA-SANTANA: Open Payments
NPI 1336732718 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 10 payments from 8 companies in 2025. Trend: 2023 $2,022 · 2024 $1,044 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $108 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Medtronic, Inc. | 1 | $36 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Dexcom G6 Transmitter, SHINGRIX, MINIMED 780G, BRIDION, TWIIST, TZIELD, LINZESS, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
